FDA Approves New Oral Contraceptive That Also Raises Folate Levels; First and Only FDA Approved Birth Control Pill with Four Indications

EGMN -- The Food and Drug Administration on Sept. 24 approved Beyaz, an oral contraceptive that contains a folate. Levomefolate calcium is a folic acid metabolite, and a B-vitamin “that helps produce and maintain new cells in the body,” according to an FDA announcement. Low folate levels in women of child-bearing age have been associated with neural tube defects, such as spina bifida; current recommendations suggest that women of child-bearing age take supplemental folate.